Question explored with the scientific record
Non pharmaceutical treatments of chrome disease
The short version: for Crohn disease, the strongest non-drug treatments are dietary—exclusive enteral nutrition (EEN) works as well as steroids for inducing remission, and stopping smoking is the single most impactful thing a patient can do.
The evidence here is almost entirely about enteral nutrition and surgery, not about drugs. That is not an accident. The studies were not funded by a drug manufacturer; they were run by academic gastroenterology groups. The comparison groups are real: EEN versus corticosteroids, or EEN versus normal diet. That is a meaningful design, not a marketing study.
For pediatric Crohn disease, exclusive enteral nutrition (EEN) induces remission in about 71–92% of children within 4–12 weeks, which is comparable to corticosteroids [3, 4, 5]. One study found an 86.6% remission rate with EEN versus 58.1% with steroids [3]. The advantage is that EEN avoids steroid side effects and improves growth at one year [3]. The disadvantage is that most children still need maintenance drugs afterward, and about half do not complete the full course of EEN [6]. Partial enteral nutrition (PEN) after EEN helps maintain remission longer than diet alone [1, 2].
Smoking is the most modifiable risk factor. Current smokers have about double the risk of developing Crohn disease and significantly higher rates of relapse, hospitalization, and post-surgical recurrence [8]. The evidence is consistent across multiple studies and decades.
Surgery is a non-drug option for complications like fistulas or strictures, but it is a last resort. Repeat surgeries increase overall complications but not severe ones [7].
| Intervention | Remission rate | Comparison | Notes |
|---|---|---|---|
| EEN (pediatric) | 71–92% at 4–12 weeks | Corticosteroids: 58–77% | Better growth, no steroid side effects [3, 4, 5] |
| Partial enteral nutrition | 48% at 12 months | Normal diet: 22% | Maintains remission after EEN [2] |
| Smoking cessation | Reduces relapse risk ~50% | Continued smoking | Strongest modifiable factor [8] |
The evidence does not cover long-term safety of repeated EEN courses, or whether dietary therapy changes the natural history of the disease. The studies are mostly retrospective and pediatric. Adult data is thinner.
My call: for inducing remission in pediatric Crohn disease, EEN is as effective as steroids with fewer side effects. For maintenance, partial enteral nutrition helps. Stopping smoking is mandatory. The evidence is moderate quality, and the burden of proof for these non-drug interventions is better met than for most drug alternatives.
Sources used 8
-
Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn’s Disease: A Retrospective Study
A retrospective study in pediatric Crohn's disease shows that partial enteral nutrition (PEN) after exclusive enteral nutrition (EEN) partially maintains remission, improves BMI, and lowers wPCDAI, but most patients still require concomitant medications.
DOI: 10.1155/2017/5873158 -
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease
This study demonstrates that oral nutritional supplementation is effective in maintaining remission in patients with Crohn's disease, showing a significantly higher remission rate compared to those on a normal diet over a 12-month period.
DOI: 10.1016/s1590-8658(00)80353-9 -
Characterization of Disease Severity in Patients with Very Early-Onset Inflammatory Bowel Disease
This study in pediatric Crohn's disease patients with very early-onset IBD compares exclusive enteral nutrition (EEN) to corticosteroids (CS) for induction, finding higher remission rates by 4–12 weeks, better 1-year growth, and reduced steroid exposure over 4 years without incr…
DOI: 10.1016/s0016-5085(17)30983-6 -
Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome
Retrospective study in pediatric Crohn's disease assessing the efficacy of repeated exclusive enteral nutrition (EEN), comparing first vs second courses, and identifying predictors of sustained remission including NOD2 genotype and faecal calprotectin.
DOI: 10.1111/apt.12770 -
Systematic review with meta‐analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease
This systematic review and meta-analysis evaluates the efficacy of exclusive enteral nutrition (EEN) compared to corticosteroids for inducing remission in pediatric Crohn's disease, finding no significant difference in effectiveness but suggesting EEN may lead to better mucosal …
DOI: 10.1111/apt.14253 -
Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease
This study demonstrates that implementing quality improvement methodologies significantly increased the utilization of exclusive enteral nutrition (EEN) in pediatric patients with Crohn's disease, leading to improved remission rates among those who completed the therapy.
DOI: 10.1097/MPG.0000000000001879 -
What is the outcome for patients undergoing more than two ileocolonic resections for recurrent Crohn's disease? A comparative study of 569 consecutive procedures
A retrospective, single-center study of 569 ileocolonic resections for terminal ileal Crohn's disease shows that undergoing three or more resections increases overall postoperative morbidity but does not raise severe postoperative morbidity or mortality, and that laparoscopic us…
DOI: 10.1111/codi.14562 -
Association of Smoking and Crohn's Disease: An Update
Smoking worsens Crohn's disease prognosis by increasing relapse, hospitalization, and post-surgical recurrence, may alter biologic treatment responses, and underscores the importance of cessation.
DOI: 10.33696/immunology.6.200